Robert Sinn, (aka Goldfinger on CEO.ca) and publisher of Goldfinger Capital on YouTube, joins me to share both his fundamental and technical outlook on the larger macroeconomic environment in the economy and general markets, and on the precious metals sector as we round out this turbulent year.
We start off getting into the recent inflation and jobs report metrics, and how those are shaping Fed policy, interest rates / real interest rates, and market expectations of potential rate cuts as soon as the end of Q1 2024. We discuss the recent boost seen in most markets to the upside as this period of central bank tightening seems to have run its course, but then move our focus over specifically to the recent moves higher in the precious metals sector.
With gold putting in it’s all-time highest close ever on the monthly charts today, Robert breaks down the technical picture in the yellow metal, along with silver, GDX, and the sector overall, and sees a nirvana set up for the precious metals sector moving into next year. We then get into the big moves up recently in Newmont and Barrick and the larger cap stocks in GDX as very constructive signs of generalist investors starting to take notice of the PM sector again. We also discuss the changing cost of capital for the junior miners, debate if there some companies that won’t be able to fund new programs, and if this may spur on more merger and acquisition transactions in the near future; noting the recent M&A deals with Calibre Mining (CXB) & Marathon Gold (MOZ), Adventus Mining (ADZN) & Luminex (LR), Silvercorp Metals (SVM) and Orecorp (ORR.AX), and Nighthawk Gold (NHK) & Moneta Gold (ME).
We wrap up with some general comments on why Robert is animated by the current valuations in the biotech stocks related to psychedelic therapy like Cybin (CYBN) and Mind Medicine (MMED), and why he considers these “medical gold” for investors to consider in the year to come.
.
.
https://www.youtube.com/@GoldfingerCapital/videos
.
https://twitter.com/ceotechnician
.